Tacrolimus Market Analysis, Overview, Size, Revenue, Growth, Demand, Research Finding by 2018 – 2026
Tacrolimus, also known as fujimycin or FK506, is an immunosuppressant drug that is used after organ transplant procedures to prevent organ rejection. The drug acts by obstructing the activation of serine-threonine phosphatase, calcineurin, in T lymphocytes. This in turn hinders activation of T lymphocyte and halts the production of cytotoxic lymphocytes that otherwise nay lead to organ rejection. Tacrolimus is used in kidney and liver transplant. Organ transplanted patients often rely on immunosuppressant therapy during their lifetime. Tacrolimus is used...
View full press release